Protara Therapeutics, Inc. - 10-Q Filing
Protara Therapeutics reports Q3 2026 financial results including updates on equity incentive plans and debt securities composition.
Tickers: $TARA
Protara Therapeutics reports Q3 2026 financial results including updates on equity incentive plans and debt securities composition.
Tickers: $TARA